St. Jude’s remote monitoring system gets FDA go-ahead

| | Cardiovascular Business | Remote Monitoring

The FDA has approved St. Jude’s next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

The newest version of Merlin.net PCN informs clinicians about changes in their patients’ heart failure status through advanced impedance and lead monitoring capabilities. It enables the remote transmission of patient data measured from CorVue Thoracic Impedance Monitoring, a diagnostic feature that tracks and reports changes in impedance that may reflect changes in heart failure status, monitored by implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators.

The algorithm assesses impedance changes in multiple vectors of the heart throughout the day and provides the flexibility to customize diagnostic reports for each patient, according to St. Paul, Minn.-based St. Jude.

The latest version also features the LeadAssurance Alert. Data from the LeadAssurance Alert offers nightly remote alert checks on high-voltage devices to ensure that lead performance is continually monitored and all diagnostics are reported to clinicians.

Merlin.net PCN gathers and stores data from the implant procedure, in-clinic follow-up visits and from remote device transmissions sent from a patient’s home. Remote transmissions are sent via a transmitter system that allows patient data from an implanted cardiac device to be wirelessly downloaded and securely transmitted for clinician review. It also allows data to be sent directly to a clinic's or a hospital's EHR system so the data are included in the patient’s comprehensive personal health record.

Related Content

Medtronic receives key FDA clearance, launches new diabetes system
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Predicting sudden cardiac death after a heart attack may be impossible—for now
Pediatric cardiology device competition introduces world to new technologies
NIH awards commercialization grant for wrist-worn continuous ICU-grade blood pressure monitor
Monitoring acute heart patients at home linked to considerable cost savings

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."